University of Oulu

Outi Varpuluoma, Laura Huilaja, Kaisa Tasanen, Reply to: “Comment on ‘Oral diabetes medications other than dipeptidyl peptidase-4 inhibitors are not associated with bullous pemphigoid: A Finnish nationwide case control study’”, Journal of the American Academy of Dermatology, Volume 79, Issue 6, 2018, Pages e113-e114, ISSN 0190-9622, https://doi.org/10.1016/j.jaad.2018.06.042

Reply to : "comment on 'oral diabetes medications other than dipeptidyl peptidase-4 inhibitors are not associated with bullous pemphigoid: a Finnish nationwide case control study'"

Saved in:
Author: Varpuluoma, Outi1; Huilaja, Laura1; Tasanen, Kaisa1
Organizations: 1PEDEGO Research Unit, University of Oulu, Department of Dermatology and Medical Research Center Oulu, Oulu University Hospital, Oulu, Finland
Format: article
Version: accepted version
Access: open
Online Access: PDF Full Text (PDF, 0.1 MB)
Persistent link: http://urn.fi/urn:nbn:fi-fe2019102835041
Language: English
Published: Elsevier, 2018
Publish Date: 2019-11-09
Series: Journal of the American Academy of Dermatology
ISSN: 0190-9622
ISSN-E: 1097-6787
ISSN-L: 0190-9622
Volume: 79
Issue: 6
Pages: E113 - E114
DOI: 10.1016/j.jaad.2018.06.042
OADOI: https://oadoi.org/10.1016/j.jaad.2018.06.042
Type of Publication: B1 Journal article
Field of Science: 3121 General medicine, internal medicine and other clinical medicine
Subjects:
Copyright information: © 2018 by the American Academy of Dermatology, Inc. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/.
  https://creativecommons.org/licenses/by-nc-nd/4.0/